Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hematologic”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableUnknownNCT04775888
What this trial is testing

Accessibility of Prophylaxis and On-demand Treatment for Persons With Haemophilia and Other Coagulation Deficiencies

Who this might be right for
Health Services AccessibilityBlood Coagulation Factor Deficiencies
RESCUe - RESeau Cardiologie Urgence / RESUVal - RESeau des Urgences de la vallée du Rhône 500
Early research (Phase 1)Ended earlyNCT03547115
What this trial is testing

Voruciclib Alone or in Combination With Venetoclax in Subjects With B-Cell Malignancies or AML

Who this might be right for
Follicular Lymphoma (FL)Mantle Cell Lymphoma (MCL)Marginal Zone Lymphoma (MZL)+4 more
MEI Pharma, Inc. 84
Testing effectiveness (Phase 2)UnknownNCT01221376
What this trial is testing

Phase II Study for Safety and Efficacy Evaluation of Imatinib Mesylate in Children With Chronic Myeloid Leukemia (CML) Philadelphia Chromosome-positive (Ph+)

Who this might be right for
Chronic Myeloid Leukemia (CML) With Philadelphia Chromosome-positive (Ph+)
Renato Melaragno 20
Early research (Phase 1)Study completedNCT00641589
What this trial is testing

Determine the Pharmacokinetic and Pharmacodynamic Profiles of PROCRIT (Epoetin Alfa) in Anemic Patients With Chronic Kidney Disease

Who this might be right for
Chronic Kidney DiseaseAnemia
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 40
Not applicableUnknownNCT02735291
What this trial is testing

Study Evaluating the Efficacy and Safety With CAR-T for Recurrent or Refractory Acute Non T Lymphocyte Leukemia

Who this might be right for
Leukemia
Sinobioway Cell Therapy Co., Ltd. 72
Testing effectiveness (Phase 2)Ended earlyNCT03381118
What this trial is testing

Haploidentical Lymphocytes With Nivolumab/Ara-C as Consolidation in Elderly AML Patients

Who this might be right for
Acute Myeloid Leukemia
St. Petersburg State Pavlov Medical University 16
Large-scale testing (Phase 3)Study completedNCT00157118
What this trial is testing

Efficacy and Safety Study of Protein C Concentrate in Subjects With Severe Congenital Protein C Deficiency

Who this might be right for
Protein C Deficiency
Baxalta now part of Shire 18
Post-approval studies (Phase 4)Not Yet RecruitingNCT07162090
What this trial is testing

Hypoxia-inducible Factor Prolyl Hydroxylase Inhibitors on Sarcopenia in Hemodialysis Patients

Who this might be right for
SarcopeniaAnemia Associated With Chronic Kidney Disease (CKD)Dialysis Patients
Tianjin Medical University General Hospital 60
Testing effectiveness (Phase 2)Study completedNCT00476190
What this trial is testing

ALL Adult Consortium Trial: Adult ALL Trial

Who this might be right for
Acute Lymphoblastic Leukemia
Dana-Farber Cancer Institute 112
Large-scale testing (Phase 3)Study completedNCT01516736
What this trial is testing

Phase III Study Comparing the Efficacy and Safety of LA-EP2006 and Peg-Filgrastim

Who this might be right for
Chemotherapy-induced NeutropeniaBreast Cancer
Sandoz 308
Large-scale testing (Phase 3)Ended earlyNCT01425307
What this trial is testing

Transcranial Doppler (TCD) With Transfusions Changing to Hydroxyurea

Who this might be right for
Sickle Cell Anemia
Children's Hospital Medical Center, Cincinnati 159
Testing effectiveness (Phase 2)Looking for participantsNCT06578507
What this trial is testing

Pharmacokinetics, Efficacy and Safety of Twice Daily Dosing Regimen of Hydroxycarbamide Dispersible Tablets in Children With Sickle Cell Disease

Who this might be right for
Sickle Cell Disease
Theravia 50
Large-scale testing (Phase 3)WithdrawnNCT00269971
What this trial is testing

Determine an Effective Dose of Epoetin Alfa to Decrease the Number of Units of Blood Required to be Transfused During Hip Replacement Surgery.

Who this might be right for
AnemiaBlood TransfusionOrthopedic Surgery
Janssen-Ortho Inc., Canada
Early research (Phase 1)Looking for participantsNCT07025564
What this trial is testing

MiRisten for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia

Who this might be right for
Recurrent Acute Myeloid LeukemiaRefractory Acute Myeloid Leukemia
City of Hope Medical Center 20
Not applicableStudy completedNCT01232387
What this trial is testing

Identification of Early Predictors of Fetomaternal Hemorrhage

Who this might be right for
Fetomaternal HemorrhageNeonatal Anemia
Icahn School of Medicine at Mount Sinai 39
Testing effectiveness (Phase 2)Study completedNCT01050621
What this trial is testing

Trial of Chemotherapy Plus Intravenous Vitamin C in Patients With Advanced Cancer for Whom Chemotherapy Alone is Only Marginally Effective

Who this might be right for
Cancer
Jewish General Hospital 14
Early research (Phase 1)Active Not RecruitingNCT03773393
What this trial is testing

A Clinical Trial of CK0801 (a New Drug) in Patients With Bone Marrow Failure Syndrome (BMF)

Who this might be right for
Bone Marrow Disease
Cellenkos, Inc. 18
Not applicableStudy completedNCT00004875
What this trial is testing

Heparin or Enoxaparin in Patients With Cancer

Who this might be right for
LymphomaThromboembolismUnspecified Adult Solid Tumor, Protocol Specific
Northwestern University 6
Large-scale testing (Phase 3)WithdrawnNCT00226512
What this trial is testing

To Determine the Role of Adding Campath-1H or ATG Given In-vivo in Addition to Fludarabine and Low Dose Busulfex on Outcome in Patients Treated With Reduced Intensity Conditioning

Who this might be right for
Acute Myeloid LeukemiaMyelodysplastic Syndrome
Hadassah Medical Organization 203
Testing effectiveness (Phase 2)Study completedNCT03548207
What this trial is testing

JNJ-68284528, a Chimeric Antigen Receptor T Cell (CAR-T) Therapy Directed Against B-Cell Maturation Antigen (BCMA) in Participants With Relapsed or Refractory Multiple Myeloma

Who this might be right for
Multiple Myeloma
Janssen Research & Development, LLC 126
Next Page